Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pure speculation, but since the company seems well cashed up to fund their current R&D pipeline, not to mention the potential milestones associated with advancing any current or new candidates in the pipeline, I would have to believe the shelf offering is for if they want to exercise their US commercialisation rights for the AZ asthma drug.
Again, pure speculation, but it seems like the only big unfunded commitment they might have.
Thanks NoNameStocks for bringing thos one to my attention, this is fun, and potentiallyvworth a whole lot more if their pulmonary delivery platform receives more validation.
PIRS wowza wow-wow...bio monster just broke free from her chains!!!
Maybe pull back and consolidate some first.
that won't be a problem
$PIRS needs to break $5.86 but having a great day so far.
PIRS look at her run!!!
PIRS heres the shift....5.50 break sends this
PIRS, short interest down -48%.
Short % Increase / Decrease
-48 %
Short Interest (Current Shares Short)
1,100,000
Shares Float
55,210,000
Short Interest (Prior Shares Short)
2,100,000
Exchange
NAS
Record Date
2021-AugB
Not much on my end. Dilution is bad but keeping the lights on is good
Any thoughts on the large $250m shelf offering?
https://www.sec.gov/Archives/edgar/data/1583648/000119312521237835/d214148ds3.htm
The stock is on the radar now but is underappreciated for the amount of money that multiple big name pharma companies are throwing at them. It almost seems like one of those stocks that you spend hours looking for reasons why its price is so low, wondering what the hell you're missing, then all of a sudden the right sets of eyeballs send the stock up and past where you thought it belonged all along.
GL!
A small retreat because of some people taking profits. AH will be awesome! PIRS is in upward mode for days ahead.
Yup, for sure my friend. But sold out early and waiting for it to find it's bottom and re-enter.
Wow, you would think this would be in the teens with that news
$PIRS already broke it's avg 10 day volume.
$PIRS finviz #'s 11.6% Insider Own: 58.6% Inst. Own:
67M - 33M - 6M = 28M
https://finviz.com/quote.ashx?t=PIRS&ty=c&ta=1&p=d
A lot of potential here
new writeup on PIRS
So much exciting stuff going on with PIRS! I wrote it up on my blog
PIRS Spells Potential
http://www.nonamestocks.com/2021/05/pirs-spells-potential.html
$PIRS Pieris: Shares Can Still Soar Much Higher, Says Analyst
https://finance.yahoo.com/news/pieris-shares-still-soar-much-223725498.html
Yup buy signal about to come in$$$
Higher lows is what we are looking for. We will see where we are end of day
This pos is trading like pinksheet junk imo
Volume is slowing down. May see some consolidation for a few days
* * $PIRS Video Chart 05-27-2021 * *
Link to Video - click here to watch the technical chart video
Agree inpatient sellers why sell for copper when gold is near
Yup
Biggest difference is we still have a good amount of sellers. Fools
Much like Tuesdays trading but at higher levels. As healthy as it gets
Pieris: Shares Can Still Soar Much Higher, Says Analyst
Source: TipRanks
There’s nothing like a slice of good news to send the stock of a micro-cap biotech on an almighty tear. On Tuesday, the blueprint was followed to a tee. Shares of Pieris Pharmaceuticals (PIRS) more than doubled in the session after it was announced that the Boston-based company had nabbed a deal that could generate it a lot of money. Specifically, the company said it was forming a partnership with Roche subsidiary Genentech to collaborate on the development of respiratory and ophthalmology therapies based on Pieris' Anticalin technology. Pieris will secure an upfront payment of $20 million and will be entitled to over $1.
https://www.tipranks.com/news/article/pieris-shares-can-still-soar-much-higher-says-analyst
Rezolute, Syros Pharmaceuticals leads healthcare gainers; NextGen Healthcare, Protagenic Therapeutics among major losers
May 27, 2021 11:06 AM ETLantheus Holdings, Inc. (LNTH), Organogenesis Holdings Inc. (ORGO), Pieris Pharmaceuticals, Inc. (PIRS)...By: Khyathi Dalal, SA News Editor
Gainers: Rezolute (NASDAQ:RZLT) +44%, Syros Pharmaceuticals (NASDAQ:SYRS) +19%, Lantheus (NASDAQ:LNTH) +17%, Pieris Pharmaceuticals (NASDAQ:PIRS) +14%, Organogenesis (NASDAQ:ORGO) +10%.
As this moves more volume will come in and we will skyrocket. Obviously isn't ihub money here. Especially when HCW is backing it up with a $9 price target
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
525
|
Created
|
06/26/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |